Penicillin G

Penicillin G, or benzylpenicillin, is the prototypical member of the beta-lactam class of antibiotics and is considered a natural penicillin because it is obtained from cultures of the fungus Penicillium rather than synthesized from scratch ^[3]. Despite the arrival of many newer agents, it remains a clinically important drug and appears on the World Health Organization's List of Essential Medicines ^[4].

The discovery of penicillin is one of the defining episodes in the history of medicine. In 1928 the Scottish bacteriologist Alexander Fleming noticed that a stray Penicillium mold contaminating a culture plate had killed the surrounding staphylococci, and he published his observation the following year ^[1]. The substance remained a laboratory curiosity until 1939, when a team at Oxford led by Howard Florey, with Ernst Chain and Norman Heatley, worked out how to isolate, purify, and produce it in quantity and demonstrated that it could cure otherwise fatal infections ^[1][2]. Large-scale manufacture was achieved in the United States during the Second World War, and in 1945 Fleming, Florey, and Chain shared the Nobel Prize in Physiology or Medicine for the achievement ^[2].

Chemically, the molecule is built around a four-membered beta-lactam ring, the reactive core shared by the whole penicillin family ^[3]. Because the compound is unstable in acid and poorly absorbed from the gut, it is administered by injection. It is supplied in several forms: highly soluble potassium and sodium salts for intravenous or intramuscular use that act quickly but briefly, and long-acting depot preparations, procaine penicillin and benzathine penicillin, that are injected into muscle and release the drug slowly over days to weeks ^[3].

Penicillin G is active mainly against gram-positive cocci such as streptococci and pneumococci, against the spirochete that causes syphilis, against Neisseria meningitidis, and against several Clostridium species ^[3]. It is used to treat streptococcal pharyngitis, pneumococcal pneumonia, syphilis, diphtheria, gas gangrene, tetanus, and certain other infections, while the long-acting benzathine form is widely used to treat syphilis and to prevent recurrences of rheumatic fever ^[3][4]. Over the decades its usefulness against some organisms, including many staphylococci, has narrowed as bacteria acquired beta-lactamase enzymes that break the drug down ^[3]. It is a prescription medicine, available generically, and its success launched the modern antibiotic era and the development of the many semisynthetic penicillins that followed ^[2][4].

Penicillin G is prescription only. The key concern is hypersensitivity, ranging from rash to life-threatening anaphylaxis, and cross-reactivity can occur among penicillins. Other effects include gastrointestinal upset and diarrhea, and very high intravenous doses can cause seizures, especially with kidney impairment. Injections can be painful, and treating syphilis may bring on a short flu-like Jarisch-Herxheimer reaction as bacteria die. The procaine and benzathine forms are for intramuscular use only and must never be given intravenously. Doses are reduced when kidney function is poor.

Probenecid is the classic penicillin G interaction and the one that was engineered on purpose: it competes for the organic anion transporter that secretes penicillin in the proximal tubule, so serum levels run higher and persist longer. This was once used to stretch a scarce supply, and it is still used when sustained concentrations are the point.

Penicillin G reduces the renal clearance of methotrexate through the same competition, and methotrexate toxicity, including myelosuppression, has followed.

Aminoglycosides are inactivated by penicillins when the two are mixed in the same solution or syringe, as the beta-lactam ring opens and attacks the aminoglycoside. This is an in vitro incompatibility, and separate administration prevents it.

Bacteriostatic agents such as tetracyclines can antagonize penicillin's bactericidal action, which depends on actively dividing cells. Penicillin G potassium also carries a substantial potassium load, so at high intravenous doses hyperkalemia becomes a real concern alongside potassium-sparing diuretics or renal impairment.

Checking a whole stack? Run it through interactions + stacks.

Penicillin G traces its origin to 1928, when the Scottish bacteriologist Alexander Fleming, working at St Mary's Hospital in London, noticed that a stray mold of the genus Penicillium had killed the staphylococci growing on one of his culture plates. Fleming named the diffusible antibacterial substance penicillin but was unable to isolate it in stable form, and the discovery lay largely dormant for a decade.

Between 1939 and 1941 a team at the University of Oxford led by Howard Florey and Ernst Chain, with the chemist Norman Heatley, purified the compound, demonstrated its dramatic effect in infected mice, and carried out the first human treatments. Wartime need drove an extraordinary Anglo-American effort to scale up production by deep-tank fermentation, so that by the Normandy landings of 1944 penicillin was available in quantity to treat wounded soldiers. Fleming, Florey, and Chain shared the 1945 Nobel Prize in Physiology or Medicine, and benzylpenicillin, the natural form now called penicillin G, became the archetype of the antibiotic era.

Penicillin G is widely regarded as one of the most consequential drugs in the history of medicine, the compound that opened the antibiotic age and transformed once-lethal infections into treatable conditions. More than eighty years after its introduction it remains a first-line, guideline-recommended therapy for syphilis, streptococcal infections, and meningococcal disease, a longevity that speaks to both its potency and its favorable safety record. Clinicians value its bactericidal action, its low cost, and its predictable behavior against susceptible organisms. Its main limitations are well understood: it is destroyed by stomach acid and so must be given by injection, it is vulnerable to bacterial beta-lactamases, and a minority of patients report allergy. Even so, its enduring place in treatment guidelines is a testament to a molecule that changed what medicine could promise.